Vanessa Hernández Selected Research

Vanessa Hernández Research Topics

Disease

7	Neoplasms (Cancer) 10/2018 - 12/2012
5	Breast Neoplasms (Breast Cancer) 01/2017 - 12/2012
4	Neoplasm Metastasis (Metastasis) 10/2018 - 04/2013
4	Colorectal Neoplasms (Colorectal Cancer) 10/2018 - 01/2015
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Adenocarcinoma 03/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Hypertension (High Blood Pressure) 12/2015
1	Aortic Aneurysm (Aneurysm, Aortic) 04/2015
1	Marfan Syndrome (Marfan's Syndrome) 04/2015
1	Ascending Aorta Aneurysm 04/2015
1	Disease Progression 01/2015

Drug/Important Bio-Agent (IBA)

3	CateninsIBA 10/2018 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 10/2018 - 12/2012
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2015
2	Celecoxib (Celebrex)FDA Link 03/2017 - 01/2015
2	glucose-regulated proteinsIBA 01/2017 - 12/2015
2	S-NitrosothiolsIBA 01/2016 - 12/2012
1	PhosphatidylserinesIBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2019
1	IsoenzymesIBA 10/2018
1	2- phenyl- 4,4,5,5- tetramethylimidazoline- 1- oxyl- 3- oxideIBA 10/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018
1	Protein Isoforms (Isoforms)IBA 10/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2018
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2017
1	Cetuximab (Erbitux)FDA Link 03/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	LigandsIBA 12/2015
1	DNA (Deoxyribonucleic Acid)IBA 12/2015
1	Bevacizumab (Avastin)FDA Link 12/2015
1	Angiogenesis InhibitorsIBA 12/2015
1	Transcription Factors (Transcription Factor)IBA 04/2015
1	myocardinIBA 04/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2015
1	AEE 788 (AEE788)IBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2013
1	Messenger RNA (mRNA)IBA 12/2012
1	Estrogen ReceptorsIBA 12/2012
1	Thioredoxin-Disulfide ReductaseIBA 12/2012
1	Auranofin (Ridaura)FDA Link 12/2012
1	S-nitrosocysteineIBA 12/2012

Therapy/Procedure

3	Therapeutics 01/2016 - 12/2012
1	Chemoradiotherapy 04/2013